Thomas N. Wight, PhD, Co-Founder
Chief Executive Officer/President
Emeritus Faculty Member, Benaroya Research Institute, Seattle, WA and Affiliate Professor of Pathology, University of Washington, Seattle, WA; Former Director, Matrix Biology Program, Benaroya Research Institute for 16 years; University of Washington faculty and Principal Investigator for 28 years in extracellular matrix biology. Expertise in the pathology of connective and vascular tissues, including skin and blood vessels. Over 360 scientific publications. Significant experience managing faculty and staff at major research institutions.
Mervyn J. Merrilees, PhD, DSc, Co-Founder
Chief Technology Officer
Honorary Associate Professor, Department of Anatomy and Medical Imaging, School of Medical Sciences, University of Auckland, New Zealand; University of Auckland faculty and Principal Investigator for over 30 years. Expertise in the structure of skin and blood vessels, atherosclerosis, and engineering of dermal and vascular tissues. Over 70 scientific publications. Extensive University faculty and staff management experience.
Anna Lewak Wight, JD, MS
Chief Business Officer
Over 30 years of legal and business experience in biotechnology and pharmaceuticals; former VP Legal Poniard Pharmaceuticals, Seattle, WA, Partner, Morrison and Foerster, Seattle, WA, Partner, Harness Dickey and Pierce, Troy, MI. Extensive experience in intellectual property and product rights procurement, management, and divestiture, and in pharmaceutical and corporate activities. Licensed to practice before USPTO.
Ingrid A. Harten, PhD
Director of Research
Staff Scientist, Benaroya Research Institute, Seattle, WA; President/Co-owner, Elefteria, Inc., Snohomish, WA. Experience in both basic research and small business administration. Research focus in extracellular matrix biology, immunology and the pathology of vascular, dermal and lung inflammatory diseases with 12 research publications.